Literature DB >> 2732676

Putative amino acid sequence of HLA-DRB chain contributing to rheumatoid arthritis susceptibility.

Y Watanabe1, K Tokunaga, K Matsuki, F Takeuchi, K Matsuta, H Maeda, K Omoto, T Juji.   

Abstract

The association between HLA-DR4 and rheumatoid arthritis (RA) has been established in many ethnic groups. To clarify the determinant of susceptibility to RA, a polymorphic segment of the HLA-DRB gene was amplified in vitro by polymerase chain reaction and analyzed with oligonucleotide probes specific for the HLA-DR4 DNA sequences. A particular sequence encoding amino acids Gln70-Arg71-Arg72-Ala73-Ala74 showed a strong association with RA (p less than 0.005, relative risk 6.0). This amino acid sequence occurs in the DRB molecules with three RA-associated specificities, DR4/Dw14, DR4/Dw15, and DR1. DR4/Dw4, which is common in Caucasian RA patients, has a strikingly similar amino acid sequence Gln70-Lys71-Arg72-Ala73-Ala74 in terms of polarity and charge profiles. Other RA nonassociated sequences differ from this sequence by at least one amino acid substitution that causes the change of the net charge. The composition of amino acid residues at the positions 70-74 may play a crucial role in the pathogenesis of RA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2732676      PMCID: PMC2189339          DOI: 10.1084/jem.169.6.2263

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis.

Authors:  A J McMichael; T Sasazuki; H O McDevitt; R O Payne
Journal:  Arthritis Rheum       Date:  1977-06

2.  A molecular basis for MHC class II--associated autoimmunity.

Authors:  J A Todd; H Acha-Orbea; J I Bell; N Chao; Z Fronek; C O Jacob; M McDermott; A A Sinha; L Timmerman; L Steinman
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

3.  HLA-DR4 in Negro and Mexican rheumatoid arthritis patients.

Authors:  Y Ueno; Y Iwaki; P I Terasaki; M S Park; E V Barnett; D Chia; S Nakata
Journal:  J Rheumatol       Date:  1981 Sep-Oct       Impact factor: 4.666

4.  Four common HLA haplotypes and their association with diseases in the Japanese population.

Authors:  T Sasazuki; H Kaneoka; N Ohta; R Hayase; I Iwamoto
Journal:  Transplant Proc       Date:  1979-12       Impact factor: 1.066

5.  HLA-DR antigens in rheumatoid arthritis in North India.

Authors:  N K Nehra; M C Vaidya; V Taneja; A Agarwal; A N Malaviya
Journal:  Tissue Antigens       Date:  1982-10

6.  HLA DR4 and rheumatoid arthritis in Japanese people.

Authors:  H Maeda; T Juji; H Mitsui; H Sonozaki; K Okitsu
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

7.  Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis.

Authors:  B Schiff; Y Mizrachi; S Orgad; M Yaron; E Gazit
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

8.  Association of HLA-DRw4 with rheumatoid arthritis in black and white patients.

Authors:  R W Karr; G E Rodey; T Lee; B D Schwartz
Journal:  Arthritis Rheum       Date:  1980-11

9.  HLA and rheumatoid arthritis in the Japanese.

Authors:  Y Nakai; A Wakisaka; M Aizawa; K Itakura; H Nakai; A Ohashi
Journal:  Arthritis Rheum       Date:  1981-05

10.  Disease associations of the Ia-like human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  A Gibofsky; R J Winchester; M Patarroyo; M Fotino; H G Kunkel
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  20 in total

Review 1.  The immunogenetics of rheumatoid arthritis.

Authors:  B P Wordsworth; J I Bell
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Polygenic susceptibility in rheumatoid arthritis.

Authors:  P Wordsworth; J Bell
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

3.  Detecting disease-predisposing variants: the haplotype method.

Authors:  A M Valdes; G Thomson
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

4.  Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis.

Authors:  C Wilson; A Thakore; D Isenberg; A Ebringer
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

5.  Pristane-induced arthritis is CD4+ T-cell dependent.

Authors:  L M Stasiuk; M Ghoraishian; C J Elson; S J Thompson
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

6.  Aneurysmal lesions of patients with abdominal aortic aneurysm contain clonally expanded T cells.

Authors:  Song Lu; John V White; Wan Lu Lin; Xiaoying Zhang; Charalambos Solomides; Kyle Evans; Nectaria Ntaoula; Ifeyinwa Nwaneshiudu; John Gaughan; Dimitri S Monos; Emilia L Oleszak; Chris D Platsoucas
Journal:  J Immunol       Date:  2014-04-21       Impact factor: 5.422

7.  HLA-DR4-restricted T-cell epitopes from the mycobacterial 60,000 MW heat shock protein (hsp 60) do not map to the sequence homology regions with the human hsp 60.

Authors:  A S Mustafa; K E Lundin; R H Meloen; T M Shinnick; A F Coulson; F Oftung
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

8.  Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study.

Authors:  N J McHugh; J Whyte; C Artlett; D C Briggs; C O Stephens; N J Olsen; N G Gusseva; P J Maddison; C M Black; K Welsh
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with Mycobacterium bovis BCG and Mycobacterium leprae.

Authors:  A S Mustafa; K E Lundin; F Oftung
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

10.  Analysis of the HLA-DR gene frequencies in Japanese cases of juveniles rheumatoid arthritis and rheumatoid arthritis by oligonucleotide DNA typing.

Authors:  H Okubo; K Itou; S Tanaka; N Watanabe; N Kashiwagi; F Obata
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.